Blood Clotting Disorders During Pregnancy: Risks & Signs

Blood clotting disorders during pregnancy are among the most dangerous complications an expecting mother can face. Pregnancy itself is a hypercoagulable state — your body ramps up clotting factor production by 20–200% to prepare for delivery. For most women, this is protective. But for those with inherited or acquired thrombophilias, this natural shift can trigger dangerous clots in the deep veins of the legs, the lungs, or even the placenta. Venous thromboembolism (VTE) remains a leading cause of maternal death in developed countries, responsible for roughly 9% of pregnancy-related deaths in the United States.

The good news: when identified early, these disorders are highly manageable. Most women with known clotting disorders go on to have healthy pregnancies with proper monitoring and anticoagulation therapy. The key is knowing your risk factors, recognizing symptoms fast, and getting the right testing done — ideally before you conceive.

What Exactly Happens to Clotting During Pregnancy?

Even in a perfectly healthy pregnancy, your blood becomes significantly more prone to clotting. Fibrinogen levels can double from a normal ~300 mg/dL to 600 mg/dL or higher by the third trimester. Factors VII, VIII, X, and von Willebrand factor all increase. Meanwhile, your body’s natural anticoagulants — protein S in particular — drop substantially.

Add in the physical compression of pelvic veins by the growing uterus (which slows venous return from the legs), reduced mobility, and potential bed rest, and you have a perfect storm for clot formation. The risk of VTE is about 5 times higher during pregnancy compared to non-pregnant women of the same age, and it climbs to 20 times higher in the first 6 weeks postpartum.

The Most Common Blood Clotting Disorders in Pregnancy

Not all thrombophilias carry the same risk. Here’s how the major disorders compare:

Antithrombin deficiency is the rarest but most dangerous inherited thrombophilia — women with this condition have up to a 30–40% chance of a VTE event during pregnancy without prophylaxis. Antiphospholipid Syndrome deserves special attention because it doesn’t just cause clots in mom — it’s directly linked to recurrent pregnancy loss, preeclampsia, placental insufficiency, and intrauterine growth restriction.

Warning Signs You Should Never Ignore

Pregnant women sometimes dismiss symptoms as “normal pregnancy discomfort.” That can be a fatal mistake. Watch for:

• Deep vein thrombosis (DVT): One-sided leg swelling, warmth, redness, and calf pain that worsens with walking. In pregnancy, DVT occurs in the left leg about 80–90% of the time due to anatomical compression of the left iliac vein.
• Pulmonary embolism (PE): Sudden shortness of breath, chest pain (especially with deep breathing), rapid heart rate, coughing up blood, or feeling faint. This is a medical emergency.
• Cerebral venous thrombosis: Severe headache unlike any you’ve had before, visual changes, seizures, or focal neurological symptoms.
• Placental clotting complications: These may not produce obvious symptoms but can manifest as unexplained fetal growth restriction, abnormal Doppler studies, or sudden onset of severe preeclampsia before 34 weeks.

Who Should Be Tested — and When

Universal thrombophilia screening for all pregnant women is not recommended by ACOG or the American Society of Hematology. Testing should be targeted based on clinical history:

• Personal history of VTE (especially if unprovoked or estrogen-related)
• First-degree relative with a high-risk thrombophilia (antithrombin, protein C/S deficiency, homozygous Factor V Leiden)
• Two or more unexplained pregnancy losses after 10 weeks
• Prior severe preeclampsia or placental abruption before 34 weeks
• History of unexplained intrauterine fetal death

Ideally, testing happens before pregnancy or at least early in the first trimester. Some tests — particularly protein S levels and lupus anticoagulant — can be unreliable during pregnancy due to normal physiological changes, so interpretation requires a clinician experienced in this area.

Standard Thrombophilia Panel

• Factor V Leiden mutation
• Prothrombin G20210A mutation
• Antithrombin activity
• Protein C activity
• Protein S activity (free and total)
• Lupus anticoagulant, anticardiolipin antibodies, anti-beta-2 glycoprotein I antibodies (for APS — must be positive on two occasions at least 12 weeks apart)

Treatment: How Clotting Disorders Are Managed in Pregnancy

The cornerstone of treatment is low-molecular-weight heparin (LMWH) — typically enoxaparin (Lovenox). Unlike warfarin, LMWH does not cross the placenta and is safe for the fetus. Dosing depends on whether you need prophylactic or therapeutic anticoagulation:

• Prophylactic dose: Enoxaparin 40 mg subcutaneously once daily (for moderate-risk patients)
• Therapeutic dose: Enoxaparin 1 mg/kg subcutaneously every 12 hours (for women with active clots or very high-risk thrombophilias)

Women with Antiphospholipid Syndrome and a history of pregnancy loss are typically treated with low-dose aspirin (81 mg daily) plus prophylactic LMWH, which has been shown to improve live birth rates from roughly 40% to over 70% in clinical trials.

Anticoagulation timing around delivery requires careful coordination. LMWH is usually held 24 hours before a planned induction or cesarean section, and epidural placement requires at least 12 hours (prophylactic dose) or 24 hours (therapeutic dose) since the last injection.

When to See a Doctor — Urgently

Call 911 or go to the emergency department immediately if you experience:

• Sudden chest pain or difficulty breathing
• Rapid or irregular heartbeat with lightheadedness
• Coughing up blood
• Sudden severe headache with vision changes

Schedule an urgent appointment with your OB or maternal-fetal medicine specialist if you notice one-sided leg swelling with pain, have had a prior pregnancy loss and haven’t been evaluated for thrombophilia, or if you have a family history of blood clots and are planning a pregnancy.

Frequently Asked Questions

Can blood clotting disorders cause miscarriage?

Yes. Both inherited thrombophilias and Antiphospholipid Syndrome are associated with recurrent pregnancy loss, particularly losses after 10 weeks’ gestation. APS is the most clearly linked — it can cause microscopic clots in the placental blood vessels that restrict blood flow to the fetus. If you’ve had two or more unexplained miscarriages, thrombophilia testing is warranted.

Is it safe to take blood thinners while pregnant?

Low-molecular-weight heparin (enoxaparin, dalteparin) is considered safe in pregnancy — it does not cross the placenta. Warfarin, on the other hand, is teratogenic (especially weeks 6–12) and is avoided during pregnancy except in rare situations like mechanical heart valves. Direct oral anticoagulants (DOACs) like rivaroxaban and apixaban are contraindicated in pregnancy.

Will I need blood thinners for every future pregnancy?

It depends on your specific diagnosis and history. A woman with antithrombin deficiency will almost certainly need anticoagulation in every pregnancy. A woman with heterozygous Factor V Leiden and no personal history of clots may only need close surveillance or low-dose prophylaxis. Each pregnancy should be individually risk-assessed with a hematologist or MFM specialist.

How long after delivery do I need to stay on blood thinners?

Postpartum anticoagulation is typically continued for at least 6 weeks, since the highest-risk period for VTE is actually the first 6 weeks after delivery — not during pregnancy itself. Women with a history of VTE may need longer courses, sometimes transitioning to warfarin or a DOAC postpartum (both are compatible with breastfeeding, with some caveats for DOACs).

Does having Factor V Leiden mean my pregnancy is high-risk?

Heterozygous Factor V Leiden — the most common inherited thrombophilia — carries a relatively modest absolute risk of about 1 in 500 per pregnancy for VTE. Without a personal or strong family history of clots, many women with heterozygous FVL have uncomplicated pregnancies with just increased vigilance. Homozygous FVL is a different story and typically requires prophylactic anticoagulation throughout pregnancy and postpartum.